Ocuphire Pharma(OCUP) - 2025 Q4 - Annual Results

Exhibit 10.1 Execution Version SECURITIES PURCHASE AGREEMENT BY AND AMONG OPUS GENETICS, INC. AND THE PURCHASERS AS SET FORTH HEREIN FEBRUARY 13, 2026 TABLE OF CONTENTS | 1. | Definitions | | 1 | | --- | --- | --- | --- | | 2. | | Purchase and Sale of Securities | 4 | | | 2.1 | Purchase and Sale | 4 | | | 2.2 | Closing | 4 | | 3. | | Representations and Warranties of the Company | 5 | | | 3.1 | Subsidiaries; Organization and Power | 5 | | | 3.2 | Capitalization | 5 | | | 3.3 | Registration Rights | 6 | | | ...